Company intelligence / Profile preview

accuFD

United States

Ownership: Private
Development stage: Other

Overview

AccuFD was commercializing a gravity array separation technology for use in blood sample separation, based on GE's groundbreaking mesoscale blood separation device. The technology optimized fluidic and gravitational principles to separate blood plasma from cells with greater than 99% accuracy[2].

Therapeutic areas: Hematology
Modalities: Device
Industry: Consumable Medical Devices

Partnerships

GE (technology partner)

Beyond the preview

Go deeper on accuFD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on accuFD.

Explore the full profile